Day: November 18, 2020

Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia

                                                                                                                                                            Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia Phase 3 trial initiated to evaluate rilzabrutinib, the...

PointClickCare Helps Senior Care Providers Enforce Best Practices for Antibiotic Stewardship Through the Use of the Infection Prevention & Control Solution

MISSISSAUGA, Ontario--(BUSINESS WIRE)--PointClickCare, the leading cloud-based software platform for the senior care market, today announced that the Infection Prevention &...

Grapefruit USA, Inc. Announces Commencement of Commercial Production of its Hourglass by Grapefruit(TM) Disruptive Time Release THC+Cannabinoid Delivery System Cream

error: Content is protected !!